NEW YORK --(BUSINESS WIRE)--Mar. 20, 2024-- DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the following members of DocGo’s leadership have recently purchased shares on the open market, as follows: - Norman
Mar 20, 2024
Company Updates 2024 Revenue Guidance to $720-$750 Million , Introduces 2024 Adjusted EBITDA Guidance 1 of $80-$85 Million Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time NEW YORK --(BUSINESS WIRE)--Feb. 28, 2024-- DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a
Feb 28, 2024
NEW YORK --(BUSINESS WIRE)--Feb. 5, 2024-- DocGo Inc . (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in February and March: BTIG at Snowbird – The 11 th Annual BTIG
Feb 05, 2024
NEW YORK --(BUSINESS WIRE)--Jan. 31, 2024-- DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that its Board of Directors has approved a new share repurchase program pursuant to which DocGo may purchase up to $36
Jan 31, 2024
NEW YORK --(BUSINESS WIRE)--Jan. 10, 2024-- DocGo Inc. (“DocGo” or the “Company”) categorically rejects this purported assessment by Fuzzy Panda Research , an obscure short seller motivated solely by profit. Their so-called “research report” uses what appears to be old, public information to
Jan 10, 2024